|
2005 Conference Publication Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonistsCooper, ME, Forbes, JM, Smith, CM, Lassila, M, Jandeleit-Dahm, KA, Allen, TJ and Calkin, AC (2005). Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER. |
|
2004 Conference Publication Inhibitors of advanced glycation end product accumulation ameliorate renal injury in the diabetic apoE knockout mouseJandeleit-Dahm, KAM, Lassila, M, Seah, KK, Allen, TJ, Thallas, V, Thomas, MC, Candido, R, Burns, WC, Forbes, JM, Calkin, AC and Cooper, ME (2004). Inhibitors of advanced glycation end product accumulation ameliorate renal injury in the diabetic apoE knockout mouse. 40th Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Munich Germany, Sep 05-09, 2004. SPRINGER. |
|
2003 Conference Publication Interference with advanced glycation end-products (AGEs) attenuates extracellular matrix (ECM) accumulation in diabetic nephropathy via protein kinase C (PKC) dependent pathways.Boner, G, Thallas, V, Cooper, ME, Rizkalla, B, Qui, ML and Forbes, JM (2003). Interference with advanced glycation end-products (AGEs) attenuates extracellular matrix (ECM) accumulation in diabetic nephropathy via protein kinase C (PKC) dependent pathways.. 36th Annual Meeting of the American-Society-of-Nephrology, San Diego California, Nov 12-17, 2003. LIPPINCOTT WILLIAMS & WILKINS. |
|
2003 Conference Publication Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711Allen, TJ, Forbes, JM, Yee, LT, Thallas, V, Thomas, MC, Candido, R, Jandeleit-Dahm, KA and Cooper, ME (2003). Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711. 76th Annual Scientific Session of the American-Heart-Association, Orlando Florida, Nov 07-12, 2003. LIPPINCOTT WILLIAMS & WILKINS. |
|
2002 Conference Publication Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.Forbes, JM, Thallas, V, Jerums, G, Thomas, MC and Cooper, ME (2002). Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.. LIPPINCOTT WILLIAMS & WILKINS. |
|
2002 Conference Publication Pivotal role of the AT2 receptor subtype in mediating angiotensin II indiced renal VEGF expression.Rizkalla, BM, Cao, ZM, Forbes, JM and Cooper, ME (2002). Pivotal role of the AT2 receptor subtype in mediating angiotensin II indiced renal VEGF expression.. LIPPINCOTT WILLIAMS & WILKINS. |
|
2002 Conference Publication Expression of connective tissue growth factor in the diabetic kidney: association with renal collagen synthesis.Cooper, ME, Cao, Z, Candido, R, Forbes, JM, Osicka, TM, Twigg, S and Bonnet, F (2002). Expression of connective tissue growth factor in the diabetic kidney: association with renal collagen synthesis.. 38th EASD Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Budapest Hungary, Sep 01-05, 2002. SPRINGER-VERLAG. |
|
2002 Conference Publication Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?Davis, BJ, Forbes, JM, Jerums, G, Cooper, ME and Allen, TJ (2002). Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?. 19th Meeting of the International-Society-for-Hypertension/12th European-Society-of-Hypertension Meeting, Prague Czech Republic, Jun 23-27, 2002. LIPPINCOTT WILLIAMS & WILKINS. |
|
2002 Conference Publication Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidineTwigg, SM, Cao, Z, Burns, WC, Brammar, G, Forbes, JM and Cooper, ME (2002). Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. AMER DIABETES ASSOC. |
|
1997 Conference Publication Artificial activation of matrix metalloproteinases.Jones, CI, Forbes, JM, Walker, RG and Becker, GJ (1997). Artificial activation of matrix metalloproteinases.. BLACKWELL SCIENCE INC. |
|
1996 Conference Publication Activation of renal type IV collagenases.Jones, CL, Forbes, JM, Walker, RG and Becker, GJ (1996). Activation of renal type IV collagenases.. AMER SOC NEPHROLOGY. |
